Dr. Gang Shi 石刚
Chief Physician
Department of Colorectal Surgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive surgery for colon and rectal cancer, including preoperative and postoperative care. Management of liver, lung, and ovarian metastases, hereditary tumors, polyps, and rectal stromal tumors. Targeted therapy, immunotherapy, genetic analysis, differential diagnosis, and nutritional support.
Dr. Shi holds a medical doctorate. Professional affiliations include roles with the Chinese Medical Doctor Association, the Liaoning Nutrition Society, and the China Branch of the International Hepato-Pancreato-Biliary Association.
Professional roles
- Member, Colorectal Tumor Group, Chinese Medical Doctor Association
- Member, Hereditary Colorectal Cancer Committee
- Member, Anorectal Surgery Group, Chinese Medical Doctor Association
- Member, China Branch of the International Hepato-Pancreato-Biliary Association
Name order: in Chinese the family name comes first (Shi Gang). Papers usually list the name as Gang Shi or Shi G.
Selected publications
13 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Eur J Cancer Prev, 2023 (senior author): Universal screening for Lynch syndrome in operated colorectal cancer by immunohistochemistry: a cohort of patients in Liaoning province, China. PubMed 36942852
- Chem Biol Interact, 2020 (senior author): Scoulerine promotes cell viability reduction and apoptosis by activating ROS-dependent endoplasmic reticulum stress in colorectal cancer cells. PubMed 32590070
- Arch Biochem Biophys, 2020 (senior author): LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p. PubMed 32590069
- Adv Clin Exp Med, 2019 (first author): Low-density lipoprotein-decorated and Adriamycin-loaded silica nanoparticles for tumor-targeted chemotherapy of colorectal cancer. PubMed 30070081
- Mol Med Rep, 2018 (senior author): Silencing Tspan1 inhibits migration and invasion, and induces the apoptosis of human pancreatic cancer cells. PubMed 30066932
- Int J Med Sci, 2017 (first author): Cell Recognition Molecule L1 Regulates Cell Surface Glycosylation to Modulate Cell Survival and Migration. PubMed 29104485
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion